Tumor-speci®c granulocyte/ macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic ecacy of activated tumor-draining lymph node cells, Cancer Immunol Immunother, vol.41, pp.317-324, 1995. ,
Large scale expansion of human tumor in®ltrating lymphocytes with surface-modi®ed stimulator cells for adoptive immuno, therapy Anticancer Res, vol.12, pp.733-736, 1992. ,
Heterogeneity of biologic responses of melanoma-speci®c CTL, J Immunol, vol.159, pp.2831-2839, 1997. ,
Suboptimal activation of melanoma in®ltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions, J Exp Med, vol.183, pp.2403-2407, 1996. ,
Selective expansion of a speci®c anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-in®ltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements, Eur J Immunol, vol.20, pp.825-831, 1990. ,
High avidity melanoma-reactive cytotoxic T lymphocytes are eciently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin Cancer Res, vol.6, pp.1459-1467, 2000. ,
Detection and quanti®cation of bloodderived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens, J Immunol Methods, vol.191, pp.131-142, 1996. ,
Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells, J Exp Med, vol.186, pp.757-766, 1997. ,
High-fold expansion of human cytotoxic T-lymphocytes speci®c for autologous melanoma cells for use in immunotherapy, J Immunother, vol.10, pp.405-411, 1991. ,
Detection of intracellular cytokines by¯ow cytometry, J Immunol Methods, vol.159, pp.197-207, 1993. ,
Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor in®ltrating T lymphocytes from 123 patients with melanoma, J Immunother, vol.23, pp.17-27, 2000. ,
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription, J Immunol, vol.158, pp.1238-1245, 1997. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482164
Frequency and relative fraction of tumor antigen-speci®c T cells among lymphocytes from melanoma-invaded lymph nodes, Int J Cancer, vol.78, pp.209-215, 1998. ,
Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice, Eur J Immunol, vol.21, pp.1403-1410, 1991. ,
T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes, Immunol Rev, vol.145, pp.167-177, 1995. ,
Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/ macrophage colony-stimulating factor) producing donor tumor-in®ltrating lymphocytes, J Immunol, vol.160, pp.334-344, 1998. ,
Speci®city, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-in®ltrating lymphocytes, Eur J Immunol, vol.22, pp.1795-1802, 1992. ,
High frequencies of naive Melan-A/MART-1-speci®c CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals, J Exp Med, vol.190, pp.705-715, 1999. ,
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-speci®c cytolytic T lymphocytes, J Exp Med, vol.188, pp.1641-1650, 1998. ,
Use of tumor-in®ltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma, N Engl J Med, vol.319, pp.1676-1680, 1988. ,
Treatment of patients with metastatic melanoma with autologous tumor-in®ltrating lymphocytes and interleukin 2, J Natl Cancer Inst, vol.86, pp.1159-1166, 1994. ,
, vitro predictors of therapeutic response in melanoma patients receiving tumor-in®ltrating lymphocytes and interleukin, 1994.
, J Clin Oncol, vol.12, pp.1475-1483
Home therapy with autologous tumour-in®l-trating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma, Eur J Cancer, vol.32, pp.735-736, 1996. ,
Expansion of human tumor in®ltrating lymphocytes for use in immunotherapy trials, J Immunol Methods, vol.102, pp.127-141, 1987. ,
Tumor-spe-ci®c cytolysis by lymphocytes in®ltrating human melanomas, J Immunol, vol.142, pp.3714-3725, 1989. ,
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers, J Immunol, vol.162, pp.2227-2234, 1999. ,